Check out our most popular compounded medications! Get Started
Codeine Phosphate 120 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredient over an extended period, providing sustained therapeutic effects. This formulation is used to treat conditions such as chronic pain, cough, dyspnea, dysuria, and dysmenorrhea. The slow release mechanism also reduces dosing frequency, enhancing patient compliance for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Codeine Phosphate 120 mg Slow Release Capsules are a specialized prescription medication designed to manage moderate to severe pain. This unique formulation incorporates Methocel E4M, a controlled-release polymer, which ensures a gradual and sustained release of the active ingredient, codeine phosphate, over an extended period. This slow-release mechanism provides consistent pain relief throughout the day, reducing the need for frequent dosing and enhancing patient compliance, particularly for medications requiring a controlled and prolonged release profile.
These capsules are versatile in their application, offering relief for a range of conditions including chronic pain, post-operative pain, and cancer-related pain. They can also be utilized for acute pain management, such as pain associated with a broken bone or severe headaches. The use of Codeine Phosphate 120 mg Slow Release Capsules should always be under the guidance of a healthcare professional, adhering strictly to the prescribed dosage to avoid potential side effects like nausea, constipation, and drowsiness.
At Bayview Pharmacy, we understand that managing pain can be complex and challenging. Our team of compounding pharmacists is committed to providing comprehensive information and support to help you navigate your treatment options. If you have any questions or concerns about Codeine Phosphate 120 mg Slow Release Capsules, please do not hesitate to reach out to us.
Codeine Phosphate 120 mg Slow Release Capsules are a compounded formulation designed for the treatment of mild to moderate pain, including pain associated with dysmenorrhea, postoperative pain, and cancer pain. The capsules are formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the active ingredient over an extended period of time. This offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
Patients should exercise caution while using Codeine Phosphate 120 mg Slow Release Capsules, especially those with a history of drug abuse, alcohol abuse, or mental health disorders. Regular monitoring for signs of addiction or abuse is recommended. This medication may interact with other medications, including other opioids, sedatives, hypnotics, anxiolytics, muscle relaxants, antihistamines, and anticholinergics. Interactions with certain herbal supplements, such as St. John's Wort, are also possible. Therefore, patients should inform their healthcare provider of all medications they are taking, including over-the-counter medications, vitamins, and herbal supplements.
Codeine Phosphate 120 mg Slow Release Capsules may cause drowsiness, dizziness, and confusion. Patients are advised not to drive or operate heavy machinery until they understand how the medication affects them. Alcohol consumption should be avoided while taking this medication. The use of Codeine Phosphate 120 mg Slow Release Capsules should be done with caution in patients with a history of gastrointestinal obstruction, asthma, or other respiratory conditions, as it may worsen these conditions. It should also be used with caution in patients with a history of head injury, seizures, or increased intracranial pressure.
If you have any questions about Codeine Phosphate 120 mg Slow Release Capsules, please reach out to your healthcare provider for further information and guidance.
Codeine Phosphate 120 mg Slow Release Capsules are a potent formulation designed to provide relief from moderate to severe pain. The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative technology allows for the gradual release of the encapsulated medication over an extended period, offering sustained therapeutic effects. This slow release mechanism provides a more consistent level of pain relief over a longer duration, reducing the need for frequent dosing and improving patient compliance.
Codeine, the active ingredient in these capsules, is an opioid analgesic. It functions by binding to opioid receptors in the brain and spinal cord, effectively blocking the transmission of pain signals to the brain. However, this formulation is not recommended for use in children under 12 years of age.
Patients are advised to take Codeine Phosphate 120 mg Slow Release Capsules as directed by their healthcare provider. The capsules should be swallowed whole with a full glass of water. It is important not to crush, chew, or break the capsules. Overdosing or taking the medication more frequently than prescribed is strongly discouraged.
Common side effects of Codeine Phosphate 120 mg Slow Release Capsules include nausea, vomiting, constipation, drowsiness, dizziness, and headache. If any of these side effects become severe or persist, patients should immediately contact their healthcare provider. Signs of an allergic reaction, such as rash, itching, or difficulty breathing, also warrant immediate medical attention.
If you have any questions or concerns about Codeine Phosphate 120 mg Slow Release Capsules, please do not hesitate to reach out to your healthcare provider or pharmacist for further information and guidance.
Codeine Phosphate 120 mg Slow Release Capsules is a medication that contains the active ingredient Codeine Phosphate. It is formulated with Methocel E4M, a type of controlled-release polymer, designed to release the medication gradually over an extended period of time.
Methocel E4M is a controlled-release polymer that allows the medication to be released gradually over an extended period of time. This offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
Slow release formulations offer several benefits. They provide sustained therapeutic effects, reduce the need for frequent dosing, and improve patient compliance, especially for medications that require a controlled and prolonged release profile.
The frequency of dosing will depend on your doctor's prescription. However, due to the slow release formulation, the frequency of dosing is typically reduced compared to regular formulations.
Codeine Phosphate is commonly used to treat moderate to severe pain. However, your doctor may prescribe it for other conditions as well. Always follow your doctor's instructions when taking this medication.
If you miss a dose, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take two doses at the same time or extra doses.
Common side effects of Codeine Phosphate include constipation, nausea, and drowsiness. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
Codeine Phosphate should only be used during pregnancy or while breastfeeding if the benefits outweigh the risks. Always consult your healthcare provider before taking any medication while pregnant or breastfeeding.
Alcohol can increase the risk of side effects from Codeine Phosphate, such as drowsiness and dizziness. It is generally recommended to avoid alcohol while taking this medication.
If you suspect an overdose, seek emergency medical attention immediately. Symptoms of an overdose may include extreme drowsiness, slow breathing, or loss of consciousness.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
